speb/financial-data huggingface dataset:
Financial ratios for HGS.NS — quarterly report dated 2025-03-31
Total revenue: 135732990.41384146
Gross profit: 132855973.81342061
Operating income: 2521627.308861351
Net income: 445405.65817161556
Capital expenditures: 0
Depreciation & amortization: 14137245.732990412
Net tangible assets: 726524433.0137947
Owner earnings: 14582651.391162027
Return on net tangible assets (%): 2.007179762787846
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.43295600420119
P/E ratio: 141.86094017384397
Shares outstanding: 46520285
Book value: 918266308.159925
P/B ratio: 0.2752389578730825
Market cap (USD): 252742661.70790058
Debt to equity: 0.24738473681865347
Current ratio: 3.211509690289075
Quick ratio: 3.2003662877680523
Effective tax rate (%): 101.63363943934267
Interest coverage ratio: 0.3937568455640744
COGS to revenue (%): 2.1196148347199975
Buyback yield (%): 0
Retained earnings: 761817862.9880757
Inventory turnover: 0.9494598765432097
Receivables turnover: 1.518757848472164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.24383902328736154
Revenue growth (%): 9.435959283900756
Rule of 40 score: 9.435959283900756
Financial ratios for HGS.NS — annual report dated 2025-03-31
Total revenue: 514867898.0593874
Gross profit: 507763619.35936403
Operating income: -31049801.26256722
Net income: 14194528.875379939
Capital expenditures: 25576338.55506196
Operating cash flow: 53445171.84942716
Depreciation & amortization: 61118774.84217909
Net tangible assets: 726524433.0137947
Owner earnings: 49736965.162497066
Return on net tangible assets (%): 6.8458764636691445
Buffett classification: The Gruesome
Stock price: 5.43295600420119
P/E ratio: 17.805639336595135
Shares outstanding: 46520285
Book value: 918266308.159925
P/B ratio: 0.2752389578730825
Market cap (USD): 252742661.70790058
Debt to equity: 0.24738473681865347
Current ratio: 3.211509690289075
Quick ratio: 3.2003662877680523
Effective tax rate (%): 296.8917112299465
Interest coverage ratio: -1.1591166972156761
COGS to revenue (%): 1.3798255293834494
SG&A to revenue (%): 5.494325844992711
Free cash flow (dilution-adjusted): 24960252.513444003
Buyback yield (%): 0
Retained earnings: 761817862.9880757
Inventory turnover: 2.3445216049382713
Receivables turnover: 5.7610140226036
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.0024869997739096
FCF margin (%): 4.847894500224787
Revenue growth (%): -6.402348247018712
Rule of 40 score: -1.554453746793925
Financial ratios for HGS.NS — quarterly report dated 2025-06-30
Total revenue: 123593494.03229582
Gross profit: 120602621.1092909
Operating income: -11655745.3779546
Net income: 2039550.6669787036
Capital expenditures: 0
Depreciation & amortization: 15016381.933068102
Owner earnings: 17055932.600046806
Buffett classification: The Gruesome
Stock price: 6.526445120524222
P/E ratio: 139.4489074588213
Shares outstanding: 46520285
Market cap (USD): 303612087.04364616
Interest coverage ratio: -1.7206771463119712
COGS to revenue (%): 2.4199274779167417
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.943659418784677
Rule of 40 score: -8.943659418784677
Financial ratios for HGS.NS — quarterly report dated 2025-09-30
Total revenue: 123003382.18714769
Gross profit: 118865839.90980834
Operating income: -10388951.521984216
Net income: -2201803.833145434
Capital expenditures: 0
Depreciation & amortization: 13326944.75760992
Net tangible assets: 727746335.9639233
Owner earnings: 11125140.924464487
Buffett classification: The Gruesome
Stock price: 5.525930101465614
Shares outstanding: 46520285
Book value: 913019165.7271701
P/B ratio: 0.2815579922744762
Market cap (USD): 257067843.2102593
Debt to equity: 0.23446251642283494
Current ratio: 3.411028669084524
Quick ratio: 3.3931589691574007
Interest coverage ratio: -1.7115527488855868
COGS to revenue (%): 3.363763015104854
Buyback yield (%): 0
Inventory turnover: 0.8752683043167182
Receivables turnover: 1.4992991617424765
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0266277034622364
Revenue growth (%): -0.47746190021452983
Rule of 40 score: -0.47746190021452983
Financial ratios for HGS.NS — quarterly report dated 2025-12-31
Total revenue: 119797259.66358472
Gross profit: 115566447.58828117
Operating income: -11849170.101370169
Net income: 4743232.705803721
Capital expenditures: 0
Depreciation & amortization: 13738442.686866436
Owner earnings: 18481675.39267016
Buffett classification: The Gruesome
Stock price: 4.961011473766292
P/E ratio: 45.915237007401714
Shares outstanding: 46520285
Market cap (USD): 230787667.64787793
Interest coverage ratio: -2.265601703940362
COGS to revenue (%): 3.5316434509307992
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.606532004693093
Rule of 40 score: -2.606532004693093
Financial ratios for IMRN — annual report dated 2021-06-30
Capital expenditures: 4984.962406015037
Buffett classification: The Gruesome
Stock price: 4.85
Shares outstanding: 8071202
Market cap (USD): 39145329.699999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRN — annual report dated 2022-06-30
Total revenue: 527719.3103448276
Gross profit: 361035.8620689655
Operating income: -2149940
Net income: -1968451.0344827587
Capital expenditures: 6929.6551724137935
Depreciation & amortization: 29383.44827586207
Net tangible assets: 15984414.48275862
Owner earnings: -1945997.2413793104
Return on net tangible assets (%): -12.17434172192128
Buffett classification: The Gruesome
Stock price: 2.14
Shares outstanding: 8071202
Book value: 15984414.482758623
P/B ratio: 1.0805758508471246
Market cap (USD): 17272372.28
Debt to equity: 0.00905135998639364
Current ratio: 15.750186297053311
Quick ratio: 15.532898728921818
Interest coverage ratio: -504.10947606727035
COGS to revenue (%): 31.585626110014076
R&D to revenue (%): 85.95413183340675
SG&A to revenue (%): 508.3044408404154
Free cash flow (dilution-adjusted): -2177821.379310345
Buyback yield (%): 0
Retained earnings: -47189848.965517245
Inventory turnover: 0.7400712846548145
Receivables turnover: 1.15431832444305
Capitalized R&D asset: 453596.551724138
ROCI (R&D-adjusted, %): -11.15732410495053
FCF margin (%): -412.6855577612446
Rule of 40 score: -412.6855577612446
Financial ratios for IMRN — annual report dated 2023-06-30
Total revenue: 1195168.8741721853
Gross profit: 866984.7682119205
Operating income: -2255973.509933775
Net income: -2507620.5298013245
Capital expenditures: 5125.165562913908
Depreciation & amortization: 32226.490066225164
Net tangible assets: 12991282.119205298
Owner earnings: -2480519.205298013
Return on net tangible assets (%): -19.093721332023165
Buffett classification: The Gruesome
Stock price: 2.02
Shares outstanding: 8071202
Book value: 12991282.119205298
P/B ratio: 1.25498221733617
Market cap (USD): 16303828.040000001
Debt to equity: 0.009639271083267455
Current ratio: 9.196961974892064
Quick ratio: 8.818451210131498
Interest coverage ratio: -352.9341069208454
COGS to revenue (%): 27.4592246378217
R&D to revenue (%): 143.6326158568852
SG&A to revenue (%): 281.3855450059705
Free cash flow (dilution-adjusted): -1723797.3509933774
Buyback yield (%): 0
Retained earnings: -47718805.29801325
Inventory turnover: 0.5899724751419102
Receivables turnover: 4.323475156916295
Capitalized R&D asset: 2020562.007535967
ROCI (R&D-adjusted, %): -8.355503687282525
Rosenberg metric: 1.1154161208232816
FCF margin (%): -144.23044209441434
Revenue growth (%): 126.4781391818363
Rule of 40 score: -17.752302912578045
Financial ratios for IMRN — annual report dated 2024-06-30
Total revenue: 3268576.6666666665
Gross profit: 2224531.3333333335
Operating income: -3477226
Net income: -4624638
Capital expenditures: 130
Depreciation & amortization: 30654
Net tangible assets: 8472962.666666666
Owner earnings: -4594114
Return on net tangible assets (%): -54.22086914266273
Buffett classification: The Gruesome
Stock price: 2.42
Shares outstanding: 8071202
Book value: 8472962.666666666
P/B ratio: 2.305251375276527
Market cap (USD): 19532308.84
Debt to equity: 0.010460016976352389
Current ratio: 5.456262164322139
Quick ratio: 4.869148296448397
Interest coverage ratio: -688.4687170010559
COGS to revenue (%): 31.94189519801178
R&D to revenue (%): 109.63918035679139
SG&A to revenue (%): 133.6173849371745
Free cash flow (dilution-adjusted): -3920222.6666666665
Buyback yield (%): 0
Retained earnings: -52645597.333333336
Inventory turnover: 0.9882999454754742
Receivables turnover: 3.533410494438851
Capitalized R&D asset: 4883484.581715764
ROCI (R&D-adjusted, %): -13.467949840634235
Rosenberg metric: 0.7908104343442722
FCF margin (%): -119.93669007814817
Revenue growth (%): 173.48241217632062
Rule of 40 score: 53.54572209817245
Financial ratios for IMRN — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 6422059.627329192
Buffett classification: The Gruesome
Stock price: 1.7
Shares outstanding: 8071202
Market cap (USD): 13721043.4
Current ratio: 6.7999890092727036
Quick ratio: 5.922604455293771
Buyback yield (%): 0
Retained earnings: -49998352.795031056
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRN — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5273892.156862745
Buffett classification: The Gruesome
Stock price: 1.74
Shares outstanding: 8071202
Book value: 5273892.156862745
P/B ratio: 2.66290835350608
Market cap (USD): 14043891.48
Debt to equity: 0.008905008083350529
Current ratio: 5.093670564181853
Quick ratio: 4.192259728106357
Buyback yield (%): 0
Retained earnings: -53884447.7124183
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMRN — annual report dated 2025-06-30
Total revenue: 4762746.405228758
Gross profit: 3114443.790849673
Operating income: -3501131.3725490198
Net income: -3409141.8300653594
Capital expenditures: 0
Depreciation & amortization: 32475.81699346405
Net tangible assets: 5273892.156862745
Owner earnings: -3376666.013071895
Return on net tangible assets (%): -64.026072445906
Buffett classification: The Gruesome
Stock price: 1.74
Shares outstanding: 8071202
Book value: 5273892.156862745
P/B ratio: 2.66290835350608
Market cap (USD): 14043891.48
Debt to equity: 0.008905008083350529
Current ratio: 5.093670564181853
Quick ratio: 4.192259728106357
Interest coverage ratio: -733.2965092402466
COGS to revenue (%): 34.60823806553093
R&D to revenue (%): 49.36592579499773
SG&A to revenue (%): 107.96096940826968
Free cash flow (dilution-adjusted): -4011077.7777777775
Buyback yield (%): 0
Retained earnings: -53884447.7124183
Inventory turnover: 1.4229043373169041
Receivables turnover: 3.7842898265625187
Capitalized R&D asset: 5318708.36777648
ROCI (R&D-adjusted, %): -34.731576249780765
Rosenberg metric: 0.24832636424569157
FCF margin (%): -84.21774825916062
Revenue growth (%): 45.713161750183566
Rule of 40 score: -38.50458650897705
Financial ratios for IPAR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 95.4
Shares outstanding: 32025781
Market cap (USD): 3055259507.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPAR — annual report dated 2022-12-31
Total revenue: 1086653000
Gross profit: 694422000
Operating income: 202052000
Net income: 151037000
Capital expenditures: 33756000
Operating cash flow: 73031000
Depreciation & amortization: 22539000
Net tangible assets: 325929000
Owner earnings: 139820000
Return on net tangible assets (%): 42.89891356706522
Capex to operating income (%): 16.706590382673767
Buffett classification: The Great
Stock price: 88.34
P/E ratio: 18.731552490714197
Shares outstanding: 32025781
Book value: 788146000
P/B ratio: 3.589636302842367
Market cap (USD): 2829157493.54
Debt to equity: 0.26603192809454085
Current ratio: 2.286127226344949
Quick ratio: 1.4445376370923506
Effective tax rate (%): 22.23366405964401
Interest coverage ratio: 56.1411503195332
COGS to revenue (%): 36.09533126030113
SG&A to revenue (%): 45.31069255778984
Free cash flow (dilution-adjusted): -20614000
Buyback yield (%): 0
Retained earnings: 620095000
Inventory turnover: 1.3525953156036195
Receivables turnover: 4.796653188784519
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.960294613449516
FCF margin (%): -1.8970177232290344
Rule of 40 score: -1.8970177232290344
Financial ratios for IPAR — annual report dated 2023-12-31
Total revenue: 1317675000
Gross profit: 839078000
Operating income: 251382000
Net income: 187776000
Capital expenditures: 6465000
Operating cash flow: 105774000
Depreciation & amortization: 17331000
Net tangible assets: 403037000
Owner earnings: 198642000
Return on net tangible assets (%): 49.28629381421557
Capex to operating income (%): 2.571783182566771
Buffett classification: The Great
Stock price: 134.28
P/E ratio: 22.90187176572086
Shares outstanding: 32025781
Book value: 892170000
P/B ratio: 4.820182109553112
Market cap (USD): 4300421872.68
Debt to equity: 0.21562258313998453
Current ratio: 2.5836456296478776
Quick ratio: 1.4385656438128378
Effective tax rate (%): 24.767120872780886
Interest coverage ratio: 22.339109570781126
COGS to revenue (%): 36.32132354336236
SG&A to revenue (%): 44.60098279165955
Free cash flow (dilution-adjusted): 49881000
Buyback yield (%): 0.35784861242949767
Retained earnings: 693848000
Inventory turnover: 1.2870389045310184
Receivables turnover: 5.168508254786364
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.065273831496558
FCF margin (%): 3.785531333598953
Revenue growth (%): 21.259960631406713
Rule of 40 score: 25.045491965005667
Financial ratios for IPAR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 123
Shares outstanding: 32025781
Market cap (USD): 3939171063
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPAR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 125.62
Shares outstanding: 32025781
Market cap (USD): 4023078609.2200003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPAR — annual report dated 2024-12-31
Total revenue: 1452325000
Gross profit: 927341000
Operating income: 278801000
Net income: 203433000
Capital expenditures: 4740000
Operating cash flow: 187642000
Depreciation & amortization: 28358000
Net tangible assets: 462387000
Owner earnings: 227051000
Return on net tangible assets (%): 49.10410543549018
Capex to operating income (%): 1.7001373739692467
Buffett classification: The Great
Stock price: 125.62
P/E ratio: 19.775939052267823
Shares outstanding: 32025781
Book value: 942645000
P/B ratio: 4.267861824143766
Market cap (USD): 4023078609.2200003
Debt to equity: 0.20388799601122373
Current ratio: 2.7867802555147447
Quick ratio: 1.667978232815024
Effective tax rate (%): 24.202748974444003
Interest coverage ratio: 35.62952076677316
COGS to revenue (%): 36.14783192467251
SG&A to revenue (%): 44.655294097395554
Free cash flow (dilution-adjusted): 162911000
Buyback yield (%): 0
Retained earnings: 763240000
Inventory turnover: 1.411550871155087
Receivables turnover: 5.16597126626899
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.84280806871122
FCF margin (%): 11.217255090974817
Revenue growth (%): 10.218756521904112
Rule of 40 score: 21.43601161287893
Financial ratios for IPAR — quarterly report dated 2025-03-31
Total revenue: 338819000
Gross profit: 215977000
Operating income: 75077000
Net income: 55403000
Capital expenditures: 1440000
Operating cash flow: -7358000
Depreciation & amortization: 5927000
Net tangible assets: 476379000
Owner earnings: 59890000
Return on net tangible assets (%): 12.571922775773073
Capex to operating income (%): 1.918030821689732
Buffett classification: The Great
Stock price: 109.47
P/E ratio: 15.819821336705592
Shares outstanding: 32025781
Book value: 1007519000
P/B ratio: 3.4796983938466672
Market cap (USD): 3505862246.07
Debt to equity: 0.182328075202552
Current ratio: 2.9729842617579973
Quick ratio: 1.6811366254311455
Effective tax rate (%): 24.53038372995873
Interest coverage ratio: 48.59352750809062
COGS to revenue (%): 36.25593606025636
SG&A to revenue (%): 41.58562536339461
Free cash flow (dilution-adjusted): -31852000
Buyback yield (%): 0
Retained earnings: 780338000
Inventory turnover: 0.3102948308612537
Receivables turnover: 1.097407245461465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.620114736780845
FCF margin (%): -9.400889560502804
Rule of 40 score: -9.400889560502804
Financial ratios for IPAR — quarterly report dated 2025-06-30
Total revenue: 333936000
Gross profit: 221089000
Operating income: 59176000
Net income: 41197000
Capital expenditures: 15191000
Operating cash flow: 11868000
Depreciation & amortization: 6364000
Net tangible assets: 506006000
Owner earnings: 32370000
Return on net tangible assets (%): 6.397157345960325
Capex to operating income (%): 25.670880086521564
Buffett classification: The Good
Stock price: 126.95
P/E ratio: 42.08771115890269
Shares outstanding: 32025781
Book value: 1056752000
P/B ratio: 3.847329267368314
Market cap (USD): 4065672897.9500003
Debt to equity: 0.26451428528169335
Current ratio: 2.9639160242762035
Quick ratio: 1.686595535749142
Effective tax rate (%): 23.885450346420324
Interest coverage ratio: 15.924650161463939
COGS to revenue (%): 33.79300225192851
SG&A to revenue (%): 48.48623688371425
Free cash flow (dilution-adjusted): -5067000
Buyback yield (%): 0.05024998447440581
Retained earnings: 787031000
Inventory turnover: 0.2653044911355146
Receivables turnover: 1.0905813193990856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.815962928088532
FCF margin (%): -1.5173566192324277
Revenue growth (%): -1.4411824602516388
Rule of 40 score: -2.9585390794840665
Financial ratios for IPAR — quarterly report dated 2025-09-30
Total revenue: 429579000
Gross profit: 272817000
Operating income: 108556000
Net income: 83279000
Capital expenditures: 5265000
Operating cash flow: 63863000
Depreciation & amortization: 6545000
Net tangible assets: 542667000
Owner earnings: 84559000
Return on net tangible assets (%): 15.582115735801144
Capex to operating income (%): 4.8500313202402445
Buffett classification: The Great
Stock price: 95.83
P/E ratio: 17.061639175390123
Shares outstanding: 32025781
Book value: 1104495000
P/B ratio: 2.778673143137814
Market cap (USD): 3069030593.23
Debt to equity: 0.20812135862996212
Current ratio: 3.2722138367688003
Quick ratio: 1.9897282782810886
Effective tax rate (%): 22.575096921746727
Interest coverage ratio: 47.09587852494577
COGS to revenue (%): 36.49200729085919
SG&A to revenue (%): 38.23766990472067
Free cash flow (dilution-adjusted): 58231000
Buyback yield (%): 0.1768636654184442
Retained earnings: 826964000
Inventory turnover: 0.40371154410742155
Receivables turnover: 1.1486284502651118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.602740203680707
FCF margin (%): 13.555364670991832
Revenue growth (%): 28.641116860715826
Rule of 40 score: 42.19648153170766
Financial ratios for IPAR — quarterly report dated 2025-12-31
Total revenue: 386175000
Gross profit: 237336000
Operating income: 27508000
Net income: 28266000
Capital expenditures: 1548000
Operating cash flow: 146527000
Depreciation & amortization: 6466000
Net tangible assets: 555531000
Owner earnings: 33184000
Return on net tangible assets (%): 5.973384023573842
Capex to operating income (%): 5.6274538316126215
Buffett classification: The Great
Stock price: 83.43
P/E ratio: 12.836776808618993
Shares outstanding: 32025781
Book value: 1104024000
P/B ratio: 2.420156544450121
Market cap (USD): 2671910908.8300004
Debt to equity: 0.1881489895147207
Current ratio: 2.9865001177315316
Quick ratio: 1.9650642581605393
Effective tax rate (%): 21.99254864081689
Interest coverage ratio: 17.075108628181255
COGS to revenue (%): 38.54185278694892
SG&A to revenue (%): 54.33495177057034
Free cash flow (dilution-adjusted): 143820000
Buyback yield (%): 0.23949151818097297
Retained earnings: 828906000
Inventory turnover: 0.4235877704004531
Receivables turnover: 1.1329763825729793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.216161998638464
FCF margin (%): 37.24218294814527
Revenue growth (%): -10.103845858386933
Rule of 40 score: 27.138337089758338
Financial ratios for IPAR — annual report dated 2025-12-31
Total revenue: 1488509000
Gross profit: 947219000
Operating income: 270317000
Net income: 208145000
Capital expenditures: 24414000
Operating cash flow: 214900000
Depreciation & amortization: 25302000
Net tangible assets: 555531000
Owner earnings: 209033000
Return on net tangible assets (%): 37.62760314005879
Capex to operating income (%): 9.031618433172904
Buffett classification: The Great
Stock price: 83.43
P/E ratio: 12.836776808618993
Shares outstanding: 32025781
Book value: 1104024000
P/B ratio: 2.420156544450121
Market cap (USD): 2671910908.8300004
Debt to equity: 0.1881489895147207
Current ratio: 2.9865001177315316
Quick ratio: 1.9650642581605393
Effective tax rate (%): 23.287706573496674
Interest coverage ratio: 37.29539183222958
COGS to revenue (%): 36.36457690212152
SG&A to revenue (%): 45.4751701198985
Free cash flow (dilution-adjusted): 165132000
Buyback yield (%): 0.5191041345788553
Retained earnings: 828906000
Inventory turnover: 1.5404821601869216
Receivables turnover: 4.367050022003814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.777892358075963
FCF margin (%): 11.093785795047259
Revenue growth (%): 2.4914533592687587
Rule of 40 score: 13.585239154316017
Financial ratios for JLP.L — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.002638888888888889
Shares outstanding: 3230841150
Market cap (USD): 8525830.8125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JLP.L — annual report dated 2022-06-30
Total revenue: 207088379.13414633
Gross profit: 67059382.29268292
Operating income: 37929783.085365854
Net income: 27175186.256097563
Capital expenditures: 53916882.719512194
Operating cash flow: 45860679.96341464
Depreciation & amortization: 15120989.780487806
Net tangible assets: 274094997.5609756
Owner earnings: -11620706.682926826
Return on net tangible assets (%): -4.239663907161117
Capex to operating income (%): 142.14919868686124
Buffett classification: The Gruesome
Stock price: 0.0017073170731707321
P/E ratio: 0.20298187486607816
Shares outstanding: 3230841150
Book value: 307523402.4390244
P/B ratio: 0.017937074747315488
Market cap (USD): 5516070.256097563
Debt to equity: 0.042538265677896654
Current ratio: 1.7327711293966181
Quick ratio: 1.3311462733468515
Effective tax rate (%): 30.68589155586543
Interest coverage ratio: 17.742476154443107
COGS to revenue (%): 67.61798871908518
Free cash flow (dilution-adjusted): -32508920.62195122
Buyback yield (%): 0
Retained earnings: 23000401.219512198
Inventory turnover: 3.4084659569956695
Receivables turnover: 2.5263015975199665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.137008714037815
FCF margin (%): -15.698090234649435
Rule of 40 score: -15.698090234649435
Financial ratios for JLP.L — annual report dated 2023-06-30
Total revenue: 216330350.63291138
Gross profit: 47846853.16455696
Operating income: 23652886.075949367
Net income: 19768421.518987343
Capital expenditures: 66971874.6835443
Operating cash flow: 63131536.708860755
Depreciation & amortization: 13644189.87341772
Net tangible assets: 278310127.84810126
Owner earnings: -33559263.29113924
Return on net tangible assets (%): -12.058225674581102
Capex to operating income (%): 283.14462120393154
Buffett classification: The Gruesome
Stock price: 0.0010126582278481013
P/E ratio: 0.16550324315349382
Shares outstanding: 3230841150
Book value: 328076872.15189874
P/B ratio: 0.009972473377833581
Market cap (USD): 3271737.8734177216
Debt to equity: 0.06934662183159458
Current ratio: 1.2584236116558996
Quick ratio: 0.8003755961235831
Effective tax rate (%): -5.60284161764314
Interest coverage ratio: 3.0046538432718344
COGS to revenue (%): 77.88250561025173
Free cash flow (dilution-adjusted): -18698279.746835444
Buyback yield (%): 0
Retained earnings: 43557303.79746835
Inventory turnover: 2.94753933478628
Receivables turnover: 20.54161733120843
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.638243735491371
FCF margin (%): -8.643391781195026
Revenue growth (%): 4.46281512145032
Rule of 40 score: -4.180576659744706
Financial ratios for JLP.L — annual report dated 2024-06-30
Total revenue: 23402178.481012657
Gross profit: 8973737.974683544
Operating income: -3103145.569620253
Net income: 8085954.4303797465
Capital expenditures: 36785726.58227848
Operating cash flow: 22321745.56962025
Depreciation & amortization: 15560881.012658227
Net tangible assets: 277163937.9746835
Owner earnings: -13138891.13924051
Return on net tangible assets (%): -4.740476425342402
Buffett classification: The Gruesome
Stock price: 0.0008860759493670887
P/E ratio: 0.3540423909000512
Shares outstanding: 3230841150
Book value: 327802173.4177215
P/B ratio: 0.008733226535360551
Market cap (USD): 2862770.6392405066
Debt to equity: 0.12065446990784426
Current ratio: 1.1299045334429194
Quick ratio: 0.8874376551503393
Effective tax rate (%): -138.14186147949476
Interest coverage ratio: -1.3536726913706771
COGS to revenue (%): 61.654262307398525
Free cash flow (dilution-adjusted): -29508181.012658224
Buyback yield (%): 0
Retained earnings: 51095149.36708861
Inventory turnover: 0.3525721195819356
Receivables turnover: 1.0386832771603651
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8735789471309815
FCF margin (%): -126.09159885093462
Revenue growth (%): -89.18220286125106
Rule of 40 score: -215.27380171218567
Financial ratios for JLP.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 167012500
Buffett classification: The Gruesome
Stock price: 0.0005
Shares outstanding: 3230841150
Book value: 303962500
P/B ratio: 0.005314539046757413
Market cap (USD): 1615420.575
Debt to equity: 0.15684089320228647
Current ratio: 1.041888560157791
Quick ratio: 0.8058678500986193
Buyback yield (%): 0
Retained earnings: 53201250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JLP.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 287571867.1232877
Buffett classification: The Gruesome
Stock price: 0.000410958904109589
Shares outstanding: 3230841150
Book value: 336760483.56164384
P/B ratio: 0.003942692219448371
Market cap (USD): 1327742.9383561644
Debt to equity: 0.08332624830103123
Current ratio: 1.279392414207093
Quick ratio: 1.2596519974929863
Buyback yield (%): 0
Retained earnings: 13945232.87671233
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JLP.L — annual report dated 2025-06-30
Total revenue: 20788610.95890411
Gross profit: -446095.8904109589
Operating income: -35058264.38356164
Net income: -40767694.52054795
Capital expenditures: 33984516.43835617
Operating cash flow: 16443616.438356165
Depreciation & amortization: 32959484.93150685
Net tangible assets: 287571867.1232877
Owner earnings: -41792726.02739727
Return on net tangible assets (%): -14.532967513640655
Buffett classification: The Gruesome
Stock price: 0.000410958904109589
Shares outstanding: 3230841150
Book value: 336760483.56164384
P/B ratio: 0.003942692219448371
Market cap (USD): 1327742.9383561644
Debt to equity: 0.08332624830103123
Current ratio: 1.279392414207093
Quick ratio: 1.2596519974929863
Interest coverage ratio: -5.79786046368325
COGS to revenue (%): 102.14586675027408
Free cash flow (dilution-adjusted): -28446671.23287671
Buyback yield (%): 0
Retained earnings: 13945232.87671233
Inventory turnover: 5.074427580246793
Receivables turnover: 1.0539402736301133
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.961116568402977
FCF margin (%): -136.83776799282748
Revenue growth (%): -11.16805225731042
Rule of 40 score: -148.0058202501379
Financial ratios for METN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2120
Shares outstanding: 251836
Market cap (USD): 533892320
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for METN.SW — annual report dated 2022-12-31
Total revenue: 702109782.6086956
Gross profit: 246404347.82608694
Operating income: 32620652.173913043
Net income: 149231521.73913044
Capital expenditures: 27956521.739130434
Operating cash flow: -6541304.347826087
Depreciation & amortization: 17417391.304347824
Net tangible assets: 488026086.9565217
Owner earnings: 138692391.3043478
Return on net tangible assets (%): 28.41905279475438
Capex to operating income (%): 85.70190929992336
Buffett classification: The Gruesome
Stock price: 1989.228260869565
P/E ratio: 3.3569267569358963
Shares outstanding: 251836
Book value: 563372826.0869565
P/B ratio: 0.8892145043343372
Market cap (USD): 500959288.30434775
Debt to equity: 0.03279934710005537
Current ratio: 1.7347131960752191
Quick ratio: 0.9483492011480654
Effective tax rate (%): 5.045370293523668
Interest coverage ratio: 94.97151898734178
COGS to revenue (%): 64.90515387628281
R&D to revenue (%): 8.458667277661583
SG&A to revenue (%): 21.566520781309748
Free cash flow (dilution-adjusted): -44355434.782608695
Buyback yield (%): 0
Retained earnings: 107753260.86956522
Inventory turnover: 3.235145688005433
Receivables turnover: 7.621812646756894
Capitalized R&D asset: 59389130.43478261
ROCI (R&D-adjusted, %): 11.240809798069352
FCF margin (%): -6.317450045747212
Rule of 40 score: -6.317450045747212
Financial ratios for METN.SW — annual report dated 2023-12-31
Total revenue: 588946428.5714285
Gross profit: 179813095.23809525
Operating income: 1017857.1428571428
Net income: 31055952.38095238
Capital expenditures: 36772619.04761905
Operating cash flow: 11329761.904761905
Depreciation & amortization: 13465476.19047619
Net tangible assets: 536135714.2857143
Owner earnings: 7748809.523809515
Return on net tangible assets (%): 1.445307469235311
Capex to operating income (%): 3612.7485380116964
Buffett classification: The Gruesome
Stock price: 1754.1785714285716
P/E ratio: 14.224819425767626
Shares outstanding: 251836
Book value: 621211904.7619048
P/B ratio: 0.7111346568343752
Market cap (USD): 441765314.71428573
Debt to equity: 0.07013939726111403
Current ratio: 1.5765199440633948
Quick ratio: 0.8593926882866084
Effective tax rate (%): 15.99201365407529
Interest coverage ratio: 1.1339522546419096
COGS to revenue (%): 69.46868398977189
R&D to revenue (%): 8.279716604509668
SG&A to revenue (%): 22.3496356488079
Free cash flow (dilution-adjusted): -31803571.42857143
Buyback yield (%): 0
Retained earnings: 111289285.71428572
Inventory turnover: 3.1912787512419794
Receivables turnover: 6.6223361533518945
Capitalized R&D asset: 88553812.6293996
ROCI (R&D-adjusted, %): 1.8811661124076735
Rosenberg metric: -1.1212700388182648
FCF margin (%): -5.4000788332676395
Revenue growth (%): -16.117615341693085
Rule of 40 score: -21.517694174960724
Financial ratios for METN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 463898888.8888889
Buffett classification: The Gruesome
Stock price: 1232.2
Shares outstanding: 251836
Book value: 540451111.1111112
P/B ratio: 0.5741727842172999
Market cap (USD): 310312319.2
Debt to equity: 0.17024049867805907
Current ratio: 1.0184301361030956
Quick ratio: 0.5357398394439509
Buyback yield (%): 0
Retained earnings: 65536666.666666664
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for METN.SW — annual report dated 2024-12-31
Total revenue: 314911111.1111111
Gross profit: 101052222.22222222
Operating income: -26973333.333333332
Net income: 58720000
Capital expenditures: 34102222.222222224
Operating cash flow: 3081111.111111111
Depreciation & amortization: 10842222.222222222
Net tangible assets: 463898888.8888889
Owner earnings: 35460000
Return on net tangible assets (%): 7.643907077452222
Buffett classification: The Gruesome
Stock price: 1232.2
P/E ratio: 5.284610340599455
Shares outstanding: 251836
Book value: 540451111.1111112
P/B ratio: 0.5741727842172999
Market cap (USD): 310312319.2
Debt to equity: 0.17024049867805907
Current ratio: 1.0184301361030956
Quick ratio: 0.5357398394439509
Effective tax rate (%): 8.292987662033422
Interest coverage ratio: -35.33624454148471
COGS to revenue (%): 67.910874320796
R&D to revenue (%): 11.703478935854914
SG&A to revenue (%): 28.785195116787804
Free cash flow (dilution-adjusted): -34586666.666666664
Buyback yield (%): 0
Retained earnings: 65536666.666666664
Inventory turnover: 3.1352500407232453
Receivables turnover: 8.814729574223247
Capitalized R&D asset: 89125242.40855764
ROCI (R&D-adjusted, %): -5.9060635198683515
Rosenberg metric: -1.6151737831921424
FCF margin (%): -10.98299343730153
Revenue growth (%): -46.52975282064757
Rule of 40 score: -57.512746257949104
Financial ratios for METN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 487911250
Buffett classification: The Gruesome
Stock price: 1312.5
Shares outstanding: 251836
Book value: 572871250
P/B ratio: 0.5769791205266455
Market cap (USD): 330534750
Debt to equity: 0
Current ratio: 0.7681669540400737
Quick ratio: 0.4003389024317736
Buyback yield (%): 0
Retained earnings: 43206250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLALE.PA — annual report dated 2021-12-31
Total revenue: 11198098.863636363
Gross profit: 1066535.2272727273
Operating income: 348471.5909090909
Net income: -1084530.6818181819
Capital expenditures: 26094.31818181818
Operating cash flow: -594580.6818181818
Depreciation & amortization: 3757.9545454545455
Net tangible assets: -2554765.909090909
Owner earnings: -1106867.0454545454
Capex to operating income (%): 7.4882196605305635
Buffett classification: The Great
Stock price: 0.03409090909090909
Shares outstanding: 10649972
Book value: -2261067.045454546
Market cap (USD): 363067.22727272724
Debt to equity: -2.1233583902210285
Current ratio: 1.666779316119344
Quick ratio: 1.666779316119344
Interest coverage ratio: 0.909947389192381
COGS to revenue (%): 90.4757473544363
SG&A to revenue (%): 6.035409622595232
Free cash flow (dilution-adjusted): -594580.6818181818
Buyback yield (%): 0
Retained earnings: -2454582.9545454546
Receivables turnover: 59.43108117073053
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.723928206206882
FCF margin (%): -5.3096573718326985
Rule of 40 score: -5.3096573718326985
Financial ratios for MLSTR.PA — annual report dated 2021-12-31
Total revenue: 37117889.77272727
Gross profit: 6242722.7272727275
Operating income: -1282593.1818181819
Net income: -1092712.5
Capital expenditures: 0
Depreciation & amortization: 1746189.7727272727
Net tangible assets: 13377613.636363637
Owner earnings: 653477.2727272727
Buffett classification: The Gruesome
Stock price: 8.068181818181818
Shares outstanding: 633379
Book value: 13393785.227272727
P/B ratio: 0.38153642492434797
Market cap (USD): 5110216.931818182
Debt to equity: 0.6405553932705051
Current ratio: 2.012451624760977
Quick ratio: 1.3422433288912865
Interest coverage ratio: -13.093454908238789
COGS to revenue (%): 83.18136411984382
Buyback yield (%): 0
Retained earnings: -1092712.5
Inventory turnover: 4.0232334924306015
Receivables turnover: 23.95139801913986
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.508569581220022
Rule of 40 score: 0
Financial ratios for MOUR.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 332.2613636363636
Shares outstanding: 395030
Market cap (USD): 131253206.47727272
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MOUR.BR — annual report dated 2022-12-31
Total revenue: 165267021.27659574
Gross profit: 39826595.74468085
Operating income: 25437234.042553194
Net income: 18371276.59574468
Capital expenditures: 1243617.0212765958
Operating cash flow: 9860638.29787234
Depreciation & amortization: 2003191.4893617022
Net tangible assets: 76651063.82978724
Owner earnings: 19130851.063829787
Return on net tangible assets (%): 24.958363404208068
Capex to operating income (%): 4.88896323867676
Buffett classification: The Great
Stock price: 304.8617021276596
P/E ratio: 6.555315716022933
Shares outstanding: 395030
Book value: 88681914.89361703
P/B ratio: 1.3579941111550964
Market cap (USD): 120429518.19148938
Debt to equity: 0
Current ratio: 2.2722042627801216
Quick ratio: 1.7921757711906194
Effective tax rate (%): 26.361349196196326
Interest coverage ratio: 747.21875
COGS to revenue (%): 75.90166783606158
Free cash flow (dilution-adjusted): 8509574.468085106
Buyback yield (%): 0
Inventory turnover: 4.48632195715862
Receivables turnover: 8.231824925816023
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.3987306251977
FCF margin (%): 5.148985201253935
Rule of 40 score: 5.148985201253935
Financial ratios for MOUR.BR — annual report dated 2023-12-31
Total revenue: 215585555.55555555
Gross profit: 54988888.88888889
Operating income: 33131111.111111112
Net income: 27084444.444444444
Capital expenditures: 1321111.111111111
Operating cash flow: 49033333.333333336
Depreciation & amortization: 2687777.7777777775
Net tangible assets: 100610000
Owner earnings: 28451111.11111111
Return on net tangible assets (%): 28.27861158047024
Capex to operating income (%): 3.9875243141726466
Buffett classification: The Great
Stock price: 431.8666666666667
P/E ratio: 6.2988291926485065
Shares outstanding: 395030
Book value: 116424444.44444445
P/B ratio: 1.4653304995132752
Market cap (USD): 170600289.33333334
Debt to equity: 0
Current ratio: 2.3303140912982743
Quick ratio: 1.9894101212203148
Effective tax rate (%): 25.178796157033673
Interest coverage ratio: 317.21276595744683
COGS to revenue (%): 74.4932406314585
Free cash flow (dilution-adjusted): 47624444.44444444
Buyback yield (%): 0.424644323450685
Inventory turnover: 6.36867151354924
Receivables turnover: 7.515474299879924
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.141783794287196
FCF margin (%): 22.090739948563858
Revenue growth (%): 30.44680898238326
Rule of 40 score: 52.53754893094712
Financial ratios for MOUR.BR — annual report dated 2024-12-31
Total revenue: 194104166.6666667
Gross profit: 53392708.333333336
Operating income: 29901041.666666668
Net income: 25439583.333333336
Capital expenditures: 2431250
Operating cash flow: 22377083.333333336
Depreciation & amortization: 2544791.666666667
Net tangible assets: 115609375
Owner earnings: 25553125.000000004
Return on net tangible assets (%): 22.10298689012029
Capex to operating income (%): 8.130987632816582
Buffett classification: The Great
Stock price: 496.3125
P/E ratio: 7.706821464253541
Shares outstanding: 395030
Book value: 129940625
P/B ratio: 1.5088301050960775
Market cap (USD): 196058326.875
Debt to equity: 0
Current ratio: 2.5787748851454824
Quick ratio: 2.1220367534456352
Effective tax rate (%): 25.498749313647735
Interest coverage ratio: 247.45689655172413
COGS to revenue (%): 72.4927551787056
Free cash flow (dilution-adjusted): 19787500
Buyback yield (%): 0.05525566552569987
Inventory turnover: 4.52918692372171
Receivables turnover: 12.937582448101091
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.23930394562428
FCF margin (%): 10.194268541375978
Revenue growth (%): -9.964206012565251
Rule of 40 score: 0.23006252881072697
Financial ratios for MOUR.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 115609375
Buffett classification: The Gruesome
Stock price: 496.3125
Shares outstanding: 395030
Book value: 129940625
P/B ratio: 1.5088301050960775
Market cap (USD): 196058326.875
Debt to equity: 0
Current ratio: 2.5787748851454824
Quick ratio: 2.1220367534456352
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MOUR.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 140035294.11764705
Buffett classification: The Gruesome
Stock price: 668.3294117647059
Shares outstanding: 395030
Book value: 156170588.2352941
P/B ratio: 1.6905242562808394
Market cap (USD): 264010167.5294118
Debt to equity: 0
Current ratio: 2.383517421365756
Quick ratio: 1.8936412324209329
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRPL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.5289463273110906
Shares outstanding: 1752598777
Market cap (USD): 927030686.3440591
Buyback yield (%): 0
Retained earnings: 834304365.0270342
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRPL.NS — annual report dated 2023-03-31
Total revenue: 13273515347.137638
Gross profit: 1027561997.5639465
Operating income: 828419123.0207065
Net income: 323435688.1851401
Capital expenditures: 85577101.09622413
Operating cash flow: 775198051.1571255
Depreciation & amortization: 144543118.14859927
Net tangible assets: 1154931059.6833131
Owner earnings: 382401705.2375152
Return on net tangible assets (%): 33.110349057749936
Capex to operating income (%): 10.330169683213011
Buffett classification: The Great
Stock price: 0.6171741778319124
P/E ratio: 3.344277545046391
Shares outstanding: 1752598777
Book value: 1201526065.773447
P/B ratio: 0.9002374064751597
Market cap (USD): 1081658709.2641902
Debt to equity: 1.717166323906595
Current ratio: 0.9888969375793081
Quick ratio: 0.42909873364058243
Effective tax rate (%): 37.60637891677309
Interest coverage ratio: 6.3530201342281885
COGS to revenue (%): 92.25855419087956
SG&A to revenue (%): 0.06162390850183373
Free cash flow (dilution-adjusted): 689598051.1571255
Buyback yield (%): 0
Retained earnings: 1093876248.4774666
Inventory turnover: 14.836174051678483
Receivables turnover: 24.382642064657134
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.44929941167398
FCF margin (%): 5.195293282316757
Rule of 40 score: 5.195293282316757
Financial ratios for MRPL.NS — annual report dated 2024-03-31
Total revenue: 10837400527.641205
Gross profit: 1034876004.3170644
Operating income: 812305432.306032
Net income: 431353879.3620338
Capital expenditures: 184864372.2268857
Operating cash flow: 845518887.1567334
Depreciation & amortization: 150771675.26082265
Net tangible assets: 1544526442.0194268
Owner earnings: 397261182.3959707
Return on net tangible assets (%): 25.72058150565311
Capex to operating income (%): 22.757987928515906
Buffett classification: The Great
Stock price: 2.542226487523992
P/E ratio: 10.329113162216554
Shares outstanding: 1752598777
Book value: 1592818803.2138143
P/B ratio: 2.79724412086405
Market cap (USD): 4455503032.891555
Debt to equity: 0.9551674547201752
Current ratio: 1.0314711406489374
Quick ratio: 0.35834218301134113
Effective tax rate (%): 34.865793541228165
Interest coverage ratio: 6.264620390074366
COGS to revenue (%): 90.4508834782144
SG&A to revenue (%): 0.08346954369145511
Free cash flow (dilution-adjusted): 658920613.9824919
Buyback yield (%): 0
Retained earnings: 1486693128.6725028
Inventory turnover: 9.84143590156018
Receivables turnover: 23.411854537993683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.335810704970395
FCF margin (%): 6.080061471400726
Revenue growth (%): -18.353200006068988
Rule of 40 score: -12.273138534668263
Financial ratios for MRPL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1421106067.8451984
Buffett classification: The Gruesome
Stock price: 2.131151457238414
Shares outstanding: 1752598777
Book value: 1469967749.6416626
P/B ratio: 2.540908423649644
Market cap (USD): 3735053437.5578117
Debt to equity: 1.099667088392623
Current ratio: 0.9181364379690812
Quick ratio: 0.40795881648121335
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRPL.NS — quarterly report dated 2024-12-31
Total revenue: 2549348408.9054666
Gross profit: 181677351.6726891
Operating income: 81551462.87446089
Net income: 36053153.04814081
Capital expenditures: 0
Owner earnings: 36053153.04814081
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.694136845786222
P/E ratio: 20.588644216713547
Shares outstanding: 1752598777
Market cap (USD): 2969142163.99557
Effective tax rate (%): 34.81009990304768
Interest coverage ratio: 2.654135053110774
COGS to revenue (%): 92.87357698782765
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRPL.NS — quarterly report dated 2025-03-31
Total revenue: 2875418517.6525598
Gross profit: 187408230.06780452
Operating income: 92577741.40752864
Net income: 43328267.477203645
Capital expenditures: 0
Net tangible assets: 1468053892.915595
Owner earnings: 43328267.477203645
Return on net tangible assets (%): 2.9514085066150075
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.536468666122068
P/E ratio: 15.53727659755338
Shares outstanding: 1752598777
Book value: 1516208440.4956741
P/B ratio: 1.776017751401009
Market cap (USD): 2692813105.1443577
Debt to equity: 1.0133961240425435
Current ratio: 0.9775906402705722
Quick ratio: 0.3468487866795002
Effective tax rate (%): 37.37814047003565
Interest coverage ratio: 3.2266226622662266
COGS to revenue (%): 93.48240164284672
Buyback yield (%): 0
Retained earnings: 1412656768.7631516
Inventory turnover: 2.9783295208142815
Receivables turnover: 7.005459662326335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5679617391735317
Revenue growth (%): 12.79033134929908
Rule of 40 score: 12.79033134929908
Financial ratios for MRPL.NS — annual report dated 2025-03-31
Total revenue: 11064474748.6556
Gross profit: 364590250.1753565
Operating income: 144213701.1924246
Net income: 6570610.240823006
Capital expenditures: 112260579.84568623
Operating cash flow: 219534603.69417813
Depreciation & amortization: 157471942.95066634
Net tangible assets: 1468053892.915595
Owner earnings: 51781973.34580311
Return on net tangible assets (%): 3.52725288871805
Capex to operating income (%): 77.84321386765932
Buffett classification: The Gruesome
Stock price: 1.536468666122068
P/E ratio: 409.826942467838
Shares outstanding: 1752598777
Book value: 1516208440.4956741
P/B ratio: 1.776017751401009
Market cap (USD): 2692813105.1443577
Debt to equity: 1.0133961240425435
Current ratio: 0.9775906402705722
Quick ratio: 0.3468485415782771
Effective tax rate (%): 52.72481053756025
Interest coverage ratio: 1.2817224232122337
COGS to revenue (%): 96.70485713549432
SG&A to revenue (%): 0.0809208955982564
Free cash flow (dilution-adjusted): 103765840.54243629
Buyback yield (%): 0
Retained earnings: 1412656768.7631516
Inventory turnover: 11.855523632017531
Receivables turnover: 26.95667815334733
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.558020322121738
FCF margin (%): 0.9378288883983803
Revenue growth (%): 2.0952830933509676
Rule of 40 score: 3.033111981749348
Financial ratios for MRPL.NS — quarterly report dated 2025-06-30
Total revenue: 2030918558.3898902
Gross profit: 71253217.87970981
Operating income: -21501287.151883923
Net income: -31670957.17294641
Capital expenditures: 0
Owner earnings: -31670957.17294641
Buffett classification: The Gruesome
Stock price: 1.642522817692488
P/E ratio: 60.33652325319029
Shares outstanding: 1752598777
Market cap (USD): 2878683481.4824486
Interest coverage ratio: -0.7144801306477953
COGS to revenue (%): 96.4915767998004
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -29.36963624871221
Rule of 40 score: -29.36963624871221
Financial ratios for MRPL.NS — quarterly report dated 2025-12-31
Total revenue: 2752773755.1520553
Gross profit: 363865433.8865991
Operating income: 266670379.8596413
Net income: 161623036.64921466
Capital expenditures: 0
Owner earnings: 161623036.64921466
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6585719059819537
P/E ratio: 13.886029202053837
Shares outstanding: 1752598777
Market cap (USD): 2906811093.990531
Effective tax rate (%): 34.64488898698654
Interest coverage ratio: 10.933047131896236
COGS to revenue (%): 86.78186199626492
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 35.54328625242614
Rule of 40 score: 35.54328625242614
Financial ratios for MVP.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3308270676691727
Shares outstanding: 112658324
Market cap (USD): 375245394.9774436
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0